Since RPE cells in AMD also suffer from lysosomal inefficiency, we need an efficient molecule that can deliver the drugs to lysosome lumen efficiently and we demonstrate the applicability of CD44 aptamer for this purpose. Here, CD44 is linked to age-related macular degeneration.